Fundraising FoxVascular Therapies
Cresskill, US · Delaware corporation · 1 known investors
Find your way into Vascular Therapies
Sign up to see every warm intro you have to Vascular Therapies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vascular Therapies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SI
Sriram IyerExecutive
Board
Investors · 1
New Science VenturesreportedGreenwich · $2M – $8Mvia Somu Subramaniam · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$78.5M disclosed across 5 rounds · 2015–2022
▶$24MraisedMar 2022 · 54 investors · BiotechnologyRule 506(b)
▶$24MraisedMar 2022 · 54 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert FlanaganDirector
- Allan TesslerDirector
- Gerald DorrosDirector
- Robert CroceDirector
- Andrew MidlerDirector
- John McDermottExecutive Officer, Director
- Sriram IyerExecutive Officer, Director
- Daniel RyanDirector
- Somu SubramaniamDirector
- Offering amount
- $25.2M
- Amount sold
- $24M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedAug 2021 · 96 investors · BiotechnologyRule 506(b)
▶$3.7MraisedAug 2021 · 96 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John McDermottExecutive Officer, Director
- Robert FlanaganDirector
- Daniel RyanDirector
- Somus SubramaniamDirector
- Sriram IyerDirector
- Andrew MidlerDirector
- Gerald DorrosDirector
- Allan TesslerDirector
- Robert CroceDirector
- Offering amount
- $4M
- Amount sold
- $3.7M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedNov 2019 · 39 investors · BiotechnologyRule 506(b)
▶$7.4MraisedNov 2019 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sriram IyerDirector
- Gerald DorrosDirector
- Allan TesslerDirector
- Robert CroceDirector
- John McDermottExecutive Officer, Director
- Kiyoshi TakesueDirector
- Andrew MidlerDirector
- Robert FlanaganDirector
- Somu SubramaniamDirector
- Daniel RyanDirector
- Offering amount
- $14.8M
- Amount sold
- $7.4M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.4MraisedOct 2018 · 29 investors · BiotechnologyRule 506(b)
▶$12.4MraisedOct 2018 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kiyoshi TakesueDirector
- Robert CroceDirector
- Sriram IyerExecutive Officer, Director
- Allan TesslerDirector
- Dan RyanDirector
- Somu SubramaniamDirector
- Robert FlanaganDirector
- Gerald DorrosDirector
- Andrew MidlerDirector
- Offering amount
- $21.1M
- Amount sold
- $12.4M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$31MraisedDec 2016 · 33 investors · BiotechnologyRule 506(b)
▶$31MraisedDec 2016 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Somu SubramaniamDirector
- Allan TesslerDirector
- Michael BambergerDirector
- Gerald DorrosDirector
- Kiyoshi TakesueDirector
- Sriram IyerExecutive Officer, Director
- Robert CroceDirector
- Robert FlanaganDirector
- Offering amount
- $31M
- Amount sold
- $31M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Vascular Therapies's investors?
- Vascular Therapies's investors include New Science Ventures.
- How much funding has Vascular Therapies raised?
- Vascular Therapies has disclosed $78.5M raised across 5 rounds.
- Where is Vascular Therapies headquartered?
- Vascular Therapies is headquartered in Cresskill, US.